Understanding the context‐specific wiring of this axis within a tumor's unique genetic and epigenetic landscape, including its integration with other core pathways such as RAS/MAPK, p53, and DDR, remains crucial for developing effective, personalized therapeutic strategies to overcome the inherent resilience of cancer cells driven by this master regulator. Here, TP53 is linked to neoplasm.